News & Updates

Show Multimedia Only
ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill
ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill
04 Mar 2026 byAudrey Abella

The phase II/III open-label ARTISTRY-1 trial shows that people living with HIV (PWH) may simplify their complex regimen (CR) by switching to a novel daily single-tablet regimen (STR) comprising bictegravir and lenacapavir (BIC+LEN).

ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill
04 Mar 2026
Rehab helps resolve platypnoea–orthodeoxia syndrome in COVID-19 patients
Rehab helps resolve platypnoea–orthodeoxia syndrome in COVID-19 patients
23 Feb 2026
Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2
Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2
13 Feb 2026